Oppenheimer Maintains Outperform on Hamilton Lane, Raises Price Target to $179

Benzinga Newsdesk www.benzinga.com Positive 89.2%

Neg 0% Neu 0% Pos 89.2%

Oppenheimer analyst Chris Kotowski maintains Hamilton Lane (NASDAQ:HLNE) with a Outperform and raises the price target from $171 to $179.